Edition:
United States

Insider Trading: Supernus Pharmaceuticals Inc (SUPN.O)

SUPN.O on Consolidated Issue listed on NASDAQ Global Market

33.20USD
27 Apr 2017
Change (% chg)

$-0.05 (-0.15%)
Prev Close
$33.25
Open
$33.35
Day's High
$33.35
Day's Low
$32.65
Volume
352,769
Avg. Vol
547,223
52-wk High
$33.65
52-wk Low
$14.14

HUDSON FREDERICK M

Institutional Holders

% Shares Owned: 92.11%
# of Holders: 316
Total Shares Held: 46,203,584
3 Mo. Net Change: 86,366
# New Positions: 7
# Closed Positions: 2
# Increased Positions: 29
# Reduced Positions: 20
# Net Buyers: 9

Officers & Directors

Name Age Since Current Position

Charles Newhall

71 2016 Independent Chairman of the Board

Jack Khattar

54 2005 President, Chief Executive Officer, Secretary, Director

Gregory Patrick

64 2011 Chief Financial Officer, Vice President

Stefan Schwabe

64 2012 Executive Vice-President - Research & Development, Chief Medical Officer

Padmanabh Bhatt

58 2012 Senior Vice President- Intellectual Property, Chief Scientific Officer

Victor Vaughn

58 2014 Senior Vice President of Sales and Marketing

Georges Gemayel

55 2015 Independent Director

Frederick Hudson

70 2010 Independent Director

William Nuerge

63 2006 Independent Director

John Siebert

76 2011 Independent Director